novotechip.com

What It Is

NovoTech Patent Firm is a U.S. patent legal services organization that provides “investor-grade” patent strategy for technology companies. Its core proposition is not simply filing patent applications, but designing patent assets around fundraising, valuation, competitive defense, and long-term portfolio leverage. It is worth noting that, based on the captured content, this is not a SaaS or enterprise software product, but a professional services firm.

Core Capabilities

Its services cover patent strategy and roadmapping, strategic patent drafting and prosecution, patent portfolio growth, continuation/divisional strategies, investor due diligence support, patentability searches, trademark clearance, provisional and non-provisional patent applications, patent assignments, and examiner interviews. Its key sectors include AI, machine learning, quantum computing, software-driven hardware, blockchain, autonomous driving/robotics, MedTech, and CleanTech. The website states that it has handled 3,700+ patent applications, served 5,000+ inventors, and emphasizes that its team has technical backgrounds in electrical engineering, computer science, applied physics, nuclear engineering, and related fields.

Pricing and Delivery

The website explicitly mentions that the IP Strategy Session is a paid strategy meeting used to assess patent defensibility, identify risk gaps, and provide investor-oriented recommendations and next steps. However, it does not disclose specific pricing, project quotes, packages, service timelines, or SLAs. There is also no information about a free version, trial, online collaboration system, API, third-party integrations, or cloud/self-hosted deployment.

Pros and Cons

The main advantage is its highly vertical positioning, making it suitable for companies with strong technical barriers where patents can affect fundraising and exits. Its “strategy before filing” methodology is valuable for avoiding low-quality patent portfolios. The downside is that its service selection appears relatively selective: it clearly does not focus on idea-stage inventors, one-off filings, or price-driven projects. In terms of information transparency, pricing and standard deliverables are only disclosed to a limited extent. As a SaaS evaluation target, its software capabilities are essentially not demonstrated.

Who It’s For and Access from China

It is better suited to Seed to Series B technology companies in the U.S. or targeting the U.S. market that are preparing for fundraising and operating in IP-sensitive markets. It is also suitable for teams that already have a product roadmap and want to build a sustainable patent portfolio. The main text does not specify access conditions from China, so this is considered unknown. If Chinese companies plan to use it, they should first confirm their need for U.S. patent protection, cross-border communication requirements, and the applicable scope of legal services.